Results 141 to 150 of about 207,267 (296)

Comparison of expression in Bulk, CD34+ and LSC to that of normal CD34+ bone marrow cells.

, 2013
The percentage of BULK (Left), CD34+ (middle) or CD34+CD38- cells (right) samples that were below, within, or above the range defined by normal CD34+ cells is shown.
Steven M. Kornblau (238855), Nianxiang Zhang (209282), Kevin R. Coombes (160319), Yi Hua Qiu (476592), Farhad Ravandi (476594), Michael Andreeff (31491), Hui Yao (240607), David Graber (476593), Jorge Cortes (189679), Amina Qutub (476590), Heather York (476591)   +10 more
core   +1 more source

Exercise‐specific plasma proteomic signatures in racehorses: Candidates for training adaptation and peak load monitoring

Equine Veterinary Journal, EarlyView.
Abstract Background Racehorses undergo profound physiological changes with training and competition, but current biomarkers inadequately capture the complex molecular dynamics of exercise. This study aimed to identify novel plasma biomarkers of training adaptation and peak load using high‐throughput proteomics.
Jowita Grzędzicka, Bianka Świderska, Ewa Sitkiewicz, Izabela Dąbrowska, Olga Witkowska‐Piłaszewicz   +4 more
wiley   +1 more source

Human CD34+/KDR+ Cells Are Generated From Circulating CD34+ Cells After Immobilization on Activated Platelets

, 2010
OBJECTIVE: To determine whether CD34(+)/kinase-insert domain-containing receptor (KDR)(+) cells are generated in the peripheral circulation (because in bone marrow and in G-CSF-mobilized peripheral blood,
Tamsma, J., de Boer, H., Boer de, H., Hovens, M., Oeveren van, A., van Oeveren, A., de Koning, E., Snoep, J., Rabelink, T.J., van Zonneveld, A.J., Huisman, M., Koning de, E., Rabelink, T. J., Zonneveld van, A.J.   +13 more
core   +1 more source

Mass culture of equine synovial fluid‐derived mesenchymal stromal cells using nonwoven polyethylene terephthalate fabrics

Equine Veterinary Journal, EarlyView.
Abstract Background Culture protocols need to yield 100 million equine synovial fluid (SF)‐derived mesenchymal stromal cells (SF‐MSCs) in around 3 weeks are needed, before these cells can be evaluated as agents of articular repair in clinical trials. Objectives To investigate mass culture of equine SF‐MSC culture protocols using nonwoven polyethylene ...
Miho Daniel Yoshitomi, Tomohide Kuramoto, Takashi Hatazoe, Kenta Mitsuda, Henry Smith, Kazuhiro Misumi   +5 more
wiley   +1 more source

Capture of CD34+ exosomes from total exosomal fractions by CD34+ microbeads.

, 2014
Isolated Kasumi-1 exosomes (Kas) and total exosome fractions isolated by ultracentrifugation from normal donor plasma (NC) or from CD34+ AML patient plasma (AML) were used for capture with CD34 microbeads.
Chang Sook Hong (610216), Laurent Muller (610217), Michael Boyiadzis (610218), Theresa L. Whiteside (262788)   +3 more
core   +1 more source

Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34− cell preparations

, 2001
Objective. The CD34 cell surface marker is used widely for stem/progenitor cell isolation. Since several recent studies reported that CD34- cells also have in vivo engrafting capacity, we quantitatively compared the engraftment potential of CD34+ vs CD34-
Wing Leung, Narda Theobald, Ramirez, Manuel, Rachata Lumkul, Harry L Malech, Gao, Zhigang, Malech, Harry L., Curt I Civin, Manuel Ramirez, Lumkul, Rachata, Zhigang Gao, Theobald, Narda, Mary Jo Fackler, Fackler, Mary Jo, Civin, Curt I., Leung, Wing   +15 more
core   +1 more source

Current Progress in Differentiating Crohn's Disease From Intestinal Tuberculosis

iLABMED, EarlyView.
Currently, there are various methods from different fields used to differentiate Crohn's disease from intestinal tuberculosis (ITB). Endoscopic findings are an important cornerstone. They can be used individually or in combination (models) to demonstrate excellent discriminative ability.
Chuyao Zhang, Xiaoyin Zhang
wiley   +1 more source

CD34

, 2021
Joachim Feger, Daniel Bell
openaire   +1 more source

Unveiling the roles of extracellular vesicles in hematologic malignancies: Pathogenesis, diagnostic tools, and clinical translation

Interdisciplinary Medicine, EarlyView.
Extracellular vesicles play pivotal roles in both healthy hematopoiesis and hematologic malignancies. They not only regulate hematopoietic stem cell fitness but also drive cancer progression and drug resistance. Their clinical potential spans from serving as non‐invasive biomarkers to acting as innovative therapeutic platforms and drug delivery ...
Fengyu Chen, Zhiyuan Wu, Feng Zhang, Yuan Meng, Hongyan Liao, Tony Y. Hu   +5 more
wiley   +1 more source

Exportin 1 Inhibitor Combined With Venetoclax Induces Apoptosis in Myelodysplastic Syndrome by Mitochondria‐Induced Apoptosis Pathway

Journal of Clinical Laboratory Analysis, EarlyView.
Inhibition of XPO1 is a promising modality in the treatment of MDS, especially when combined with Venetoclax, which activates mitochondria‐mediated apoptosis and could be a potential target for MDS therapy. ABSTRACT Background Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat.
Xiaohan Liu, Lei Huang, Junzhu Wang, Yixuan Guo, Hongli Shen, Xianghong Zhao, Lanzhu Yue, Zhaoyun Liu, Rong Fu   +8 more
wiley   +1 more source